GMED
Undervalued by 199% based on the discounted cash flow analysis.
Market cap | $7.83 Billion |
---|---|
Enterprise Value | $7.53 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.76 |
Beta | 1.21 |
Outstanding Shares | 136,757,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 42.65 |
---|---|
PEG | -3.68 |
Price to Sales | 3.23 |
Price to Book Ratio | 2.01 |
Enterprise Value to Revenue | 3 |
Enterprise Value to EBIT | 44.83 |
Enterprise Value to Net Income | 40 |
Total Debt to Enterprise | 0.02 |
Debt to Equity | 0.04 |
No data
No data